
Funders are increasingly making global access to healthcare IP a condition of their grants.
Our pick of spinout technologies that are breaking new ground in plastics recycling, data storage, photonics, semiconductor materials and decoding the genome.
The European venture capital firm aims to raise a total €250m for its fourth fund by next year.
Ian McClure is expanding his role from associate vice president for research, innovation and economic impact at the University of Kentucky to include vice president of innovation for UK Healthcare, the institution's health system.
The technology transfer veteran has been made head of the German teaching hospital's new technology transfer office.
Centro National de Análisis Genómico was the first national sequencing centre in Europe.
EMV Capital will manage a portfolio of 53 deep tech and life sciences companies as part of the acquisition.
James Chan, who holds a similar position at other funds, has joined the investment firm affiliated with the University of California.
From a chest-worn device to help with Parkinson's symptoms to stress measuring socks — here are the spinouts providing support for senior citizens.
Basel has quietly built a life sciences ecosystem that’s becoming hard to ignore.
What if living to 100 was the norm rather than the exception for humans? Here are 10 companies using university research to make it happen.
GV backs another spinout by MIT’s serial entrepreneur Feng Zhang as epigenetics becomes an emerging area of healthcare.
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
Startups often find the UK's National Health Service hard to sell into. These three tips can stop founders falling at the first hurdle.
UK smartphone camera component developer Cambridge Mechatronics’ latest round featured strategic investors Sony Ventures and Intel Capital.
Brendan Bulik-Sullivan, Crystal Huang, Frédérique Dame and Issi Rozen have been promoted from partner positions at the early-stage Alphabet fund.
Wana Schulze and Ivan Yoon will lead CVC investments at Telefónica’s seed and early-stage Brazilian subsidiaries.